ERBB2 and cancer: As shown in Figure 7A,B, AC-NKs with T-DM1 significantly enhanced cancer cell death in HER2-postive cancer cells such as SK-BR-3 (52.03 ± 1.65) and BT-474 (16.50 ± 5.85) compared to the other treatment groups.